The streaming video giant is slated to give investors its first-quarter earnings update in . This approach enables the accurate synthesis of thousands of sequences on a single chip to meet the demand for complex libraries and assembly of long DNA in days rather than weeks, accelerating research across the exciting field of synthetic biology. It not only unlocks measurable improvements in productivity, quality and safety but also enables a smooth transfer of knowledge between the retiring and new generation of workers to improve market resiliency. 6sense keeps track of 20 - 49 employees who To find emails, direct dials, and more for prospects across the web. Personalize which data points you want to see and create visualizations instantly. Zyme Communications Raquel is an experienced R&D leader with a track-record of taking new ideas from concept phase to commercialised products in the Next Generation Sequencing (NGS) space. The platform has the potential to revolutionise the way this DNA is prepared and delivered to users in the rapidly growing field of synthetic biology, accelerating research in applications across pharma, biotech, food, agriculture, and data storage. EquityZen helps investors to access private companies and their employees to sell shares. Before joining Evonetix, Matthew was Head of Technology for the Global Medtech Division of Cambridge Consultants. The Company has raised $30 million USD (23 million GBP) in this round, which was led by new investor Foresite Capital. We are a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. Interview with Dr Matthew Hayes, Chief Technology Officer, Team Talk Daniel Bygrave, Group Head of Software, Evonetix closes $24 million USD (20 million) financing. Evonetix is included in 4 Expert Collections, including Agriculture Technology (Agtech). Ulta Beauty (NASDAQ: ULTA), which sells cosmetics, seems to have defied this paradigm. Operator of a biotechnology company intended to synthesize DNA at higher accuracy and scale. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Developing a new paradigm for gene synthesis to facilitate the fast-growing and exciting field of synthetic biology. To ensure the most secure and best overall experience on our website, we recommend the latest versions of. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. By continuing to use this site you are consenting to these choices. affect the user interaction and engagement with the company. The group is managed by investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Evonetix brings together the talents of an astonishing group of scientists and engineers, across biology, physics, electronics, chemistry, software and mechanics; all with the same mission, to unlock the capabilities of semiconductor technology for the world of synthetic biology. and which sectors. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. information on technology stack, industry listing, and other details. He has experience working in a broad range of roles in start-ups, large corporations, government and consultancy. Zaptic was founded by Richard Milnes in 2012 in the UK to address this issue faced by manufacturers. February 7, 2023 10:51 PM UTC. He has also held board positions at Psynova Neurotech, Bioscale and Enigma Diagnostics. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. BSE - Scrip Code: 539437 Sub. You can read more about your. Plus: Evonetix tops off series B and updates from Aldeyra, Neuron23, Slingshot and more. He is a Fellow of the Royal Society and The Academy of Medical Sciences and the Royal Society of Chemistry (RSC), and has received numerous awards including a Royal Medal and Interdisciplinary Award of the RSC. Competitors of Evonetix include Catalog Technologies. Date. The Company develops technology that enables the parallel synthesis of DNA on silicon arrays. He focussed on Programme and Line Management in the UK before taking a secondment to the US to lead the expansion of the Boston site into Industrial and Consumer. By combining DNA polymer synthesis technology, electronic nano-switches and semiconductor fabrication technologies, Iridia is developing a highly-parallel format to enable an array of nanomodules with the potential to store data at exceptionally high density. evonetix is seeking to develop and commercialise a new approach to the synthesis of DNA. During the last three decades Jim has been a thought partner for some of the most impactful and fastest growth companies of their generation including: 10x Genomics (NASDAQ: TXG), Amerigroup (NASDAQ: ANTM), and Jazz Pharmaceuticals (NASDAQ: JAZZ). A live simulcast of Bloomberg Television. Prior to that, Raquel was a post-doctoral researcher in the Department of Chemical Engineering and Biotechnology, University of Cambridge, in the area of cancer gene therapy. His previous roles include Director level positions in Marketing and Product Management at Thermo Fisher Scientific and Arcis Biotechnology, leadership of the Cell and Molecular Research Tools business segment at GE Healthcare and head of Marketing & Business Development at Promega UK. At MIT, he founded MIT Solve, the Institutes open innovation platform, which deploys capital and other resources toward solutions to grand challenges; chaired the MIT Enterprise Forum, the Institutes global entrepreneurial community; and was senior advisor to MITs 16th President, Susan Hockfield. He works with some of Cambridge Consultants largest clients, helping them maximise the value of innovation. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. The 3 most popular patent topics include: Molecular biology, Error detection and correction, Genetics, Biotechnology, DNA. He has delivered commercial success in numerous leadership positions, including Vice President and General Manager and Vice President of Sales at Thermo Fisher Scientific, Vice President and Head of European Sales at Life Technologies and National Sales Manager at Qiagen. Cambridge, England, United Kingdom. Matt Hayes, Founder and Chief Technology Officer at Evonetix, said: We have been working on optimising the different elements of our technology ready to share DNA with researchers. Evonetix. At MIT, he founded MIT Solve, the Institutes open innovation platform, which deploys capital and other resources toward solutions to grand challenges; chaired the MIT Enterprise Forum, the Institutes global entrepreneurial community; and was senior advisor to MITs 16th President, Susan Hockfield. Java is a programming language and computing platform. He completed his PhD at the University of Cambridge. Professor Andrew Briggs is Professor of Nanomaterials at the University of Oxford, where his research focuses on materials and techniques for quantum information technologies and investigating vibrational states of nanotubes and charge transport through single molecules in graphene nanogaps. Draper Esprit was founded in 2006 with a mission to back Europes most ambitious entrepreneurs. The technical storage or access that is used exclusively for anonymous statistical purposes. Evonetix is a Cambridge . April 23, 2023 06:50 am EDT. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Reaching this point in our development is a key milestone, paving the way for the expansion in scale that only semiconductor-based technologies can achieve., Colin McCracken, CEO of Evonetix added: Biology is driving a revolution that will change the way we live and help solve some of the biggest problems faced by our planet today. September 09, 2020 08:00 AM Eastern Daylight Time. His investments include Napo Pharmaceuticals, Glenmark, Renovo, Phagenesis. He is a Fellow of the Royal Society and The Academy of Medical Sciences and the Royal Society of Chemistry (RSC), and has received numerous awards including a Royal Medal and Interdisciplinary Award of the RSC. Explore 47 technologies across 13 categories used by lorna.cuddon@zymecommunications.com, Internet Explorer presents a security risk. He has also worked in operational and general management roles in both Toronto, Canada and Sydney , Australia. You can read more about your cookie choices at our privacy policyhere. Our network is truly global, with key advisors located in Silicon Valley, Cambridge and NY in the US, as well as Europe and Asia. Hermann holds an MA in Physics from Vienna University and a PhD in Physics from the University of Cambridge. In addition to publishing nearly 600 peer-reviewed scientific papers, he is the author of several books that address scientific issues in the context of a broader humanist debate. The platform aims to deliver less expensive, higher quality, reduced turn-around-time oligonucleotide synthesis solutions. Malcolm has worked globally (being based in the UK and Australia) and also across a range of industries. See more March 02, 2020 02:00 AM Eastern Standard Time. Evonetix is ready to meet these challenges and open the door to the exciting next phase of our development., To apply to be included in the early access program, please visit: www.evonetix.com/access, Lorna Cuddon This is a profile preview from the PitchBook Platform. Mammen joined Cambridge Consultants as Chief Financial Officer in 2005. ", Paul Beastall, Chair of the Board of Directors at Evonetix, said: "Were delighted to have secured additional funding from our existing investors in this oversubscribed round, testament not only to the promise of our novel approach to gene synthesis, but also the unrivalled expertise of our interdisciplinary team. and M.A in humanities fields completely unrelated to his investment interests. Jason was raised in Berkeley and on a farm on the North Coast of California, where his family raised game birds for restaurants in the Bay Area. Among his operational responsibilities at DCVC, he helps portfolio companies tell their stories. Roku (NASDAQ: ROKU) stock is trouncing the market so far in 2023, but that rally will soon be tested. Researchers are invited to apply to receive DNA that has been synthesised using Evonetix's platform. Evonetix's headquarters is located at 9A Coldhams Business Park, Norman Way, Cambridge. The Company will then look to scale up the parallel synthesis capacity of its semiconductor chips as it works toward future full commercialisation of its technology. By digitising processes and making knowledge more accessible to frontline workers, Zaptic is helping manufacturers significantly improve productivity, reduce waste and better meet customer demands. 9a Coldham's Business Park, Norman Way. Use Slintel to connect with top decision-makers at Evonetix Ltd. She also acted as a Consultant for projects in collaboration with Genomics England, Technology Development and Applications, and Customer Support. Building a platform capable of this requires highly parallel, distributed synthesis. The companys vision is to be the operating system for frontline execution, with insight and best practices shared within and across companies, raising standards and improving workforce productivity across supply chains. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. March 2, 2020. He holds a PhD and MEng in Electronic Engineering, both from Loughborough University. In addition to this, the company will use the investment to develop its no-code platform that will help manufacturers bridge the existing skills gap and digitise daily operations in such a way that it closes the data loop and brings in the use of AI in factories. At the core of this is the ability to deliver DNA better and faster to researchers working on these global challenges. To add symbols: Type a symbol or company name. EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. By BioCentury Staff. Our Bioengineering Platform will enable independent synthesis of thousands of distinct DNA strands per run, allowing 100s of kilobases of DNA to be assembled into genes and providing DNA pools forCRISPR Screening, Antibody Discovery, Target Enrichment, Saturation Mutagenesis and more. 6sense Chrome Extension. Even during times of high inflation and recession fears, its business appears to do quite well. clicking here. Jim Tananbaum is the founder and chief executive officer of Foresite Capital, a U.S.-focused healthcare investment firm founded in 2011 that has $3 billion in assets under management. Cambridge. Check the background of this firm on FINRAs BrokerCheck. The investment round was led by London VC Molten Ventures that recently backed Evonetix and Hadean , with participation from existing investors. The company is . Raquel is an experienced R&D leader with a track-record of taking new ideas from concept phase to commercialised products in the Next Generation Sequencing (NGS) space. Jason was raised in Berkeley and on a farm on the North Coast of California, where his family raised game birds for restaurants in the Bay Area. Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions. His interests include understanding the influence of new technologies and how society views their potential impact on human flourishing. Description. He has also worked in operational and general management roles in both Toronto, Canada and Sydney , Australia. Use this section to learn 1. Malcolm also worked in both the assurance and consultancy practices of PwC.